Are IRBs inherently conflicted in their work? Whether they’re part of an institution or a private, independent IRB, they have stakeholders who have an interest in IRB review outcomes, and who potentially can exert pressure on IRBs, according to a recent article in Nature Medicine. Authors Jonathan M. Green and Stephen Rosenfeld, who both have a deep commitment to and expertise in human research protections, argue that publicly funded, not-for-profit IRBs may help mitigate some of these competing interests. Read the article to learn more.